Skip to main content

Freed Inmates To Get Naloxone Doses From Sheriff

Freed Inmates To Get Naloxone Doses From Sheriff

Freed Inmates To Get Naloxone Doses From Sheriff

Introduction

The Orleans Parish Sheriff's Office has announced the delivery of 2,000 naloxone, opioid reversal pills, to individuals freed from New Orleans' central jail as part of a nationwide campaign to minimize drug overdose deaths.

The anti-opiate medicines are being distributed after the US Food and Drug Administration authorized the treatment for over-the-counter sale on March 29. Anyone discharged from the Orleans Justice Center will be given Kloxxado, a brand-name nasal spray form of naloxone.

The Sheriff's Office, the Recently Incarcerated Transitions Clinic, the NGO Voice of the Experienced, and the manufacturer Hikma Pharmaceuticals collaborated on the initiative.

Individuals leaving jails and prisons are up to 129 times more likely to die from an overdose, according to the Sheriff's Office, since their tolerance for narcotics drops while jailed.

Fentanyl, a synthetic opioid up to 50 times stronger than heroin, was a role in 94% of overdose-related deaths in New Orleans in 2021, according to the Sheriff's Office, making naloxone distribution even more critical. Overdose deaths in New Orleans in 2021 were more than five times higher than in 2015.

The contribution was praised by the executive director of UNITY of Greater New Orleans, the city's largest supplier of homeless services. She claims that homeless individuals are prone to substance misuse because drugs and alcohol help them sleep or relieve pain in stressful and dangerous settings.

Hikma Pharmaceuticals contributed 2,000 eight-milligram nasal naloxone dosages to the Recently Incarcerated Clinic, which then distributed them to the Sheriff's Office. After the original supply of naloxone is depleted, the Sheriff's Office intends to apply to the Louisiana Department of Health for more, according to a spokeswoman.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!